SHELDON STEPHEN (Chief Financial Officer) reported 1 transaction at KUVATRIS THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/14/2024ACC: 0001104659-24-034555
Officer· Chief Financial Officer
Since Aug 2022
-3.36K
Net shares
Net seller
$2.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
3.36K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.36K
Price / share
$0.69
Trade value
$2.32K
% of position
24.9%
3/12/2024
13.49K→10.14K
Total
Net shares
−3.36K
Net value
-$2.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/12/2024 | F · Tax Withholding | −3.36K | $0.69 | $2.32K | 24.9% | 13.49K | 10.14K |
| Total | −3.36K | -$2.32K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.11K
Total
1.11K indirect1.11K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.11K | Indirect |
| Total | 1.11K | 1.11K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported